title: Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.
abstract: Recent reports have revealed the existence of widespread extensively drug-resistant (XDR) P. aeruginosa high-risk clones in health care settings, but there is still scarce information on their specific chromosomal (mutational) and acquired resistance mechanisms. Up to 20 (10.5%) of 190 bloodstream isolates collected from 10 Spanish hospitals met the XDR criteria. A representative number (15 per group) of isolates classified as multidrug-resistant (MDR) (22.6%), resistant to 1 to 2 classes (moderately resistant [modR]) (23.7%), or susceptible to all antibiotics (multiS) (43.2%) were investigated in parallel. Multilocus sequence typing (MLST) analysis revealed that all XDR isolates belonged to sequence type 175 (ST175) (n = 19) or ST111 (n = 1), both recognized as international high-risk clones. Clonal diversity was higher among the 15 MDR isolates (4 ST175, 2 ST111, and 8 additional STs) and especially high among the 15 modR (13 different STs) and multiS (14 STs) isolates. The XDR/MDR pattern in ST111 isolates correlated with the production of VIM-2, but none of the ST175 isolates produced acquired β-lactamases. In contrast, the analysis of resistance markers in 12 representative isolates (from 7 hospitals) of ST175 revealed that the XDR pattern was driven by the combination of AmpC hyperproduction, OprD inactivation (Q142X), 3 mutations conferring high-level fluoroquinolone resistance (GyrA T83I and D87N and ParC S87W), a G195E mutation in MexZ (involved in MexXY-OprM overexpression), and the production of a class 1 integron harboring the aadB gene (gentamicin and tobramycin resistance). Of particular interest, in nearly all the ST175 isolates, AmpC hyperproduction was driven by a novel AmpR-activating mutation (G154R), as demonstrated by complementation studies using an ampR mutant of PAO1. This work is the first to describe the specific resistance markers of widespread P. aeruginosa XDR high-risk clones producing invasive infections.
authors.affiliation: Servicio de Microbiología y Unidad de Investigación, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Cabot
authors.forename: Alain A
authors.initials: AA
authors.lastname: Ocampo-Sosa
authors.forename: M Angeles
authors.initials: MA
authors.lastname: Domínguez
authors.forename: Juan F
authors.initials: JF
authors.lastname: Gago
authors.forename: Carlos
authors.initials: C
authors.lastname: Juan
authors.forename: Fe
authors.initials: F
authors.lastname: Tubau
authors.forename: Cristina
authors.initials: C
authors.lastname: Rodríguez
authors.forename: Bartolomé
authors.initials: B
authors.lastname: Moyà
authors.forename: Carmen
authors.initials: C
authors.lastname: Peña
authors.forename: Luis
authors.initials: L
authors.lastname: Martínez-Martínez
authors.forename: Antonio
authors.initials: A
authors.lastname: Oliver
mesh_terms: D002999:Clone Cells; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D016521:Electrophoresis, Gel, Pulsed-Field; D005816:Genetic Complementation Test; D005819:Genetic Markers / Q000235:genetics*; D008826:Microbial Sensitivity Tests; D009154:Mutation / Q000235:genetics; D016133:Polymerase Chain Reaction; D011552:Pseudomonas Infections / Q000453:epidemiology / Q000235:genetics / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics*; D013030:Spain / Q000453:epidemiology
chemical_list: D005819:Genetic Markers